BackOrient Pharma , Ltd. Overview

Orient Pharma , Ltd. Total Liabilities

Latest total liabilities for 4166.TWO: $350M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$353.90M
↓ 48.95% YoYΔ $-339.39M vs prior year quarter

Peer trimmed avg / median

Loading

Orient Pharma , Ltd. Total Liabilities History

Loading

Orient Pharma , Ltd. vs. peers: Total Liabilities Comparison

Loading

Orient Pharma , Ltd. Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Orient Pharma , Ltd. (4166.TWO) FAQ

Orient Pharma , Ltd. posts a total liabilities of $350M as of June 2026. That compares with $690M in the prior-year period — down 49.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Orient Pharma , Ltd.'s total liabilities was $690M. The latest reading is $350M — a 49.0% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Total Liabilities is one piece of Orient Pharma , Ltd.'s financial statement story. At $350M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 4166.TWO's total liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Orient Pharma , Ltd.'s other metric pages and overview cover the third.